NCT02717949 2019-01-08OptimalUniversity of Texas Southwestern Medical CenterPhase 4 Terminated1 enrolled
NCT03261349 2017-08-25Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell LymphomaNational Taiwan University HospitalPhase 2 Unknown21 enrolled